| Progesterone receptor modulates ERα action in breast cancer H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ... Nature 523 (7560), 313-317, 2015 | 707 | 2015 |
| Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer BIG 1-98 Collaborative Group New England Journal of Medicine 361 (8), 766-776, 2009 | 631 | 2009 |
| Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial J Cuzick, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, JF Forbes The lancet oncology 16 (1), 67-75, 2015 | 493 | 2015 |
| Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical … MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ... The lancet oncology 12 (12), 1101-1108, 2011 | 451 | 2011 |
| Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ... Cancer research 69 (15), 6131-6140, 2009 | 442 | 2009 |
| Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International … G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ... Journal of clinical oncology 26 (34), 5569, 2008 | 398 | 2008 |
| Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience G Berclaz, S Li, KN Price, AS Coates, M Castiglione-Gertsch, ... Annals of Oncology 15 (6), 875-884, 2004 | 341 | 2004 |
| Androgens induce divergent proliferative responses in human breast cancer cell lines SN Birrell, JM Bentel, TE Hickey, C Ricciardelli, MA Weger, DJ Horsfall, ... The Journal of steroid biochemistry and molecular biology 52 (5), 459-467, 1995 | 316 | 1995 |
| Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII A Wallgren, M Bonetti, RD Gelber, A Goldhirsch, M Castiglione-Gertsch, ... Journal of Clinical Oncology 21 (7), 1205-1213, 2003 | 315 | 2003 |
| Breast and prostate cancer: more similar than different GP Risbridger, ID Davis, SN Birrell, WD Tilley Nature Reviews Cancer 10 (3), 205-212, 2010 | 306 | 2010 |
| Role of the androgen receptor in human breast cancer SN Birrell, RE Hall, WD Tilley Journal of mammary gland biology and neoplasia 3, 95-103, 1998 | 164 | 1998 |
| The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ... Nature medicine 27 (2), 310-320, 2021 | 136 | 2021 |
| Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells JM Bentel, SN Birrell, MA Pickering, DJ Holds, DJ Horsfall, WD Tilley Molecular and cellular endocrinology 154 (1-2), 11-20, 1999 | 127 | 1999 |
| Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer SN Birrell, LM Butler, JM Harris, G Buchanan, WD Tilley The FASEB Journal 21 (10), 2285-2293, 2007 | 112 | 2007 |
| MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression RE Hall, SN Birrell, WD Tilley, RL Sutherland European Journal of Cancer 30 (4), 484-490, 1994 | 104 | 1994 |
| Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer RE Hall, JO Aspinall, DJ Horsfall, SN Birrell, JM Bentel, RL Sutherland, ... British journal of cancer 74 (8), 1175-1180, 1996 | 102 | 1996 |
| Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors EJ Cops, T Bianco-Miotto, NL Moore, CL Clarke, SN Birrell, LM Butler, ... The Journal of steroid biochemistry and molecular biology 110 (3-5), 236-243, 2008 | 95 | 2008 |
| Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. SN Birrell, DM Roder, DJ Horsfall, JM Bentel, WD Tilley Journal of clinical oncology 13 (7), 1572-1577, 1995 | 95 | 1995 |
| A patient‐derived explant (PDE) model of hormone‐dependent cancer MM Centenera, TE Hickey, S Jindal, NK Ryan, P Ravindranathan, ... Molecular oncology 12 (9), 1608-1622, 2018 | 94 | 2018 |
| Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for … MM Regan, KN Price, A Giobbie-Hurder, B Thürlimann, RD Gelber, ... Breast Cancer Research 13, 1-16, 2011 | 92 | 2011 |
